<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutations of the N-ras oncogene and p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene were simultaneously investigated in bone marrow cells from 44 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-derived <z:hpo ids='HP_0001909'>leukemia</z:hpo> by single-strand conformation polymorphism (SSCP) analysis followed by direct sequencing </plain></SENT>
<SENT sid="1" pm="."><plain>The mutations of the N-ras gene were detected only in two cases with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-derived <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Three patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-derived <z:hpo ids='HP_0001909'>leukemia</z:hpo> and one with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts exhibited five mutations of the p53 gene </plain></SENT>
<SENT sid="3" pm="."><plain>No concomitant mutations of both genes were observed in our study, suggesting that alterations of both genes could play an important role in the progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in a non-cooperative manner </plain></SENT>
</text></document>